Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Cardiopulmonary insufficiency; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority (RA)-WEB, regulatory authority number AT-BASGAGES-2021-33611. An 89-year-old female patient received bnt162b2 (COMIRNATY), dose 2 intramuscular on 18Jun2021 (Lot Number: FD0168) as single dose for COVID-19 immunisation. Medical history included ongoing carotid artery stenosis (ACI-Stenosis), ongoing dementia dementia, ongoing intervertebral disc protrusion (discus protrusion L4/L5). Concomitant medications were not reported. Previously the patient received the first dose of COMIRNATY (Lot # EY7015) on 07May2021 for COVID-19 immunisation. The patient experienced cardiopulmonary insufficiency (medically significant) on 24Jun2021. The patient died on 24Jun2021 from cardiopulmonary insufficiency. An autopsy was not performed. Sender''s comment: comment: No further information available. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: Cardiorespiratory insufficiency
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166